BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15497)

  • 1. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K; Gondo H; Nomoto K
    J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active suppression of in vitro reactivity of spleen cells after BCG treatment.
    Orbach-Arbouys S; Poupon MF
    Immunology; 1978 Mar; 34(3):431-7. PubMed ID: 305890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [BCG-induced T cell anergy and its activation by IL-4].
    Nishioka Y; Nakanishi K; Sugita M
    Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary in vitro cytotoxic response of F1 T lymphocytes against parental antigens.
    Ishikawa H; Dutton RW
    J Immunol; 1979 Feb; 122(2):529-36. PubMed ID: 310842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J x DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity.
    Clark DA; Chaput A; Tutton D
    J Immunol; 1986 Mar; 136(5):1668-75. PubMed ID: 2936806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice.
    Lagrange PH; Hurtrel B
    Ann Immunol (Paris); 1979; 130C(5):687-709. PubMed ID: 393159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice.
    Gros P; Skamene E; Forget A
    J Immunol; 1981 Dec; 127(6):2417-21. PubMed ID: 6795274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 19. H-2 I region restriction phenomenon in T cell-dependent granuloma formation to Mycobacterium bovis BCG.
    Ueda K; Yamazaki S; Yamamoto S
    J Reticuloendothel Soc; 1983 Dec; 34(6):475-84. PubMed ID: 6418887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sister chromatid exchanges in spleen and thymus lymphocytes from AKR, C57BL/6N x DBA/2J F1, and CBA mice following in vivo exposure to N-methyl-N-nitrosourea.
    Neft RE; Schol HM; Casciano DA
    Cancer Res; 1989 Aug; 49(16):4504-8. PubMed ID: 2787206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.